Bengaluru now has a new cancer treatment centre launched by OnCare, aiming to bring accessible, affordable, and patient-friendly oncology services to the region. Following success in Delhi-NCR, the facility offers comprehensive care including chemotherapy, immunotherapy, and supportive services.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4oBSebW
via IFTTT
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
-
The Indian Pharmaceutical Alliance lauds the upcoming GST reforms, effective Monday, as a transformative step towards affordable healthcare....
-
India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 milli...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(407)
-
▼
July
(12)
- OnCare launches cancer treatment centre in Bengaluru
- Fortis Healthcare inks pact with Dion Group for 30...
- Sun Pharma secures relief in 'Pantocid' trademark ...
- Syngene International MD & CEO Peter Bains resigns
- Zydus Lifesciences ties up with Apollo Hospitals t...
- New rules simplify drug launches, reduce manufactu...
- Shantha Biologics to make injectable drug cartridg...
- Generics must not be imperiled over data protectio...
- Telangana bets big on drug discovery hub
- Mankind Pharma partners Denovo Sciences for AI-led...
- mRNA vaccines protect against severe infectious di...
- Mankind Pharma joins hands with Denovo Sciences fo...
-
▼
July
(12)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment